These findings demonstrate that under suboptimal and stressful growing conditions, loss of PTEN protein function triggers a failsafe mechanism in a cell-autonomous manner, that can be exploited in combination therapies with AKT inhibitors for breast cancer treatment [64]. Here, PTEN is linked to breast carcinoma.